FR2905600B1 - Traitement des vertiges par l'acetyl-l-leucine. - Google Patents

Traitement des vertiges par l'acetyl-l-leucine.

Info

Publication number
FR2905600B1
FR2905600B1 FR0607992A FR0607992A FR2905600B1 FR 2905600 B1 FR2905600 B1 FR 2905600B1 FR 0607992 A FR0607992 A FR 0607992A FR 0607992 A FR0607992 A FR 0607992A FR 2905600 B1 FR2905600 B1 FR 2905600B1
Authority
FR
France
Prior art keywords
vertigs
leucine
acetyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0607992A
Other languages
English (en)
Other versions
FR2905600A1 (fr
Inventor
Pierre Fabre
Christophe Przybylski
Anne Sophie Saurel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR0607992A priority Critical patent/FR2905600B1/fr
Priority to TW096134031A priority patent/TW200817030A/zh
Priority to US12/310,908 priority patent/US20090318555A1/en
Priority to ARP070104058A priority patent/AR062784A1/es
Priority to EP07825741A priority patent/EP2068860A2/fr
Priority to MX2009002725A priority patent/MX2009002725A/es
Priority to NZ576150A priority patent/NZ576150A/en
Priority to CA002663206A priority patent/CA2663206A1/fr
Priority to JP2009527922A priority patent/JP2010503658A/ja
Priority to PCT/IB2007/003644 priority patent/WO2008032222A2/fr
Priority to AU2007297181A priority patent/AU2007297181B2/en
Publication of FR2905600A1 publication Critical patent/FR2905600A1/fr
Priority to ZA200901452A priority patent/ZA200901452B/xx
Priority to FR0951944A priority patent/FR2943537B1/fr
Application granted granted Critical
Publication of FR2905600B1 publication Critical patent/FR2905600B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
FR0607992A 2006-09-13 2006-09-13 Traitement des vertiges par l'acetyl-l-leucine. Expired - Fee Related FR2905600B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0607992A FR2905600B1 (fr) 2006-09-13 2006-09-13 Traitement des vertiges par l'acetyl-l-leucine.
TW096134031A TW200817030A (en) 2006-09-13 2007-09-12 Treatment of vertigo with acetyl-l-leucine
PCT/IB2007/003644 WO2008032222A2 (fr) 2006-09-13 2007-09-13 Traitement des vertiges avec de l'acétyl-l-leucine
EP07825741A EP2068860A2 (fr) 2006-09-13 2007-09-13 Traitement des vertiges avec de l'acétyl-l-leucine
MX2009002725A MX2009002725A (es) 2006-09-13 2007-09-13 Tratamiento del vertigo con acetil-l-leucina.
NZ576150A NZ576150A (en) 2006-09-13 2007-09-13 Use of acetyl-L-leucine in the treatment of vestibular neuritis
US12/310,908 US20090318555A1 (en) 2006-09-13 2007-09-13 Treatment of Vertigo with Acetyl-L-Leucine
JP2009527922A JP2010503658A (ja) 2006-09-13 2007-09-13 アセチル−ｌ−ロイシンによるめまいの治療
ARP070104058A AR062784A1 (es) 2006-09-13 2007-09-13 Tratmiento de los vertigos con acetil -l- leucina
AU2007297181A AU2007297181B2 (en) 2006-09-13 2007-09-13 Treatment of vertigo with acetyl-L-leucine
CA002663206A CA2663206A1 (fr) 2006-09-13 2007-09-13 Traitement des vertiges avec de l'acetyl-l-leucine
ZA200901452A ZA200901452B (en) 2006-09-13 2009-03-02 Treatment of vertigo with acetyl-L-leucine
FR0951944A FR2943537B1 (fr) 2006-09-13 2009-03-25 Traitement des nevrites vestibulaires par l'acetyl-l-leucine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0607992A FR2905600B1 (fr) 2006-09-13 2006-09-13 Traitement des vertiges par l'acetyl-l-leucine.

Publications (2)

Publication Number Publication Date
FR2905600A1 FR2905600A1 (fr) 2008-03-14
FR2905600B1 true FR2905600B1 (fr) 2010-01-15

Family

ID=37709503

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0607992A Expired - Fee Related FR2905600B1 (fr) 2006-09-13 2006-09-13 Traitement des vertiges par l'acetyl-l-leucine.
FR0951944A Expired - Fee Related FR2943537B1 (fr) 2006-09-13 2009-03-25 Traitement des nevrites vestibulaires par l'acetyl-l-leucine

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR0951944A Expired - Fee Related FR2943537B1 (fr) 2006-09-13 2009-03-25 Traitement des nevrites vestibulaires par l'acetyl-l-leucine

Country Status (12)

Country Link
US (1) US20090318555A1 (fr)
EP (1) EP2068860A2 (fr)
JP (1) JP2010503658A (fr)
AR (1) AR062784A1 (fr)
AU (1) AU2007297181B2 (fr)
CA (1) CA2663206A1 (fr)
FR (2) FR2905600B1 (fr)
MX (1) MX2009002725A (fr)
NZ (1) NZ576150A (fr)
TW (1) TW200817030A (fr)
WO (1) WO2008032222A2 (fr)
ZA (1) ZA200901452B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TN2010000251A1 (fr) * 2010-06-03 2011-11-11 Rekik Raouf N-acetyl-dl-leucine medicament neuro et retino protecteur
CA3021155A1 (fr) * 2016-04-19 2017-10-26 Intrabio Ltd Acetyl-leucine ou sel pharmaceutiquement acceptable de celle-ci pour une mobilite amelioree et une fonction cognitive
EP4342461A2 (fr) 2016-08-11 2024-03-27 IntraBio Ltd Compositions pharmaceutiques et utilisations contre des troubles du stockage lysosomal
IL264641B1 (en) * 2016-08-11 2024-03-01 Intrabio Ltd Acetyl-leucine for use in the treatment of neurodegenerative diseases
GB201709459D0 (en) * 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2941924A (en) * 1956-03-30 1960-06-21 Rhone Poulenc Sa Monoethanolamine salt of alpha-(acetylamino)-isocaproic acid
GB798680A (en) * 1956-03-30 1958-07-23 Rhone Poulenc Sa Improvements in or relating to the preparation of pharmaceutical compositions

Also Published As

Publication number Publication date
AR062784A1 (es) 2008-12-03
US20090318555A1 (en) 2009-12-24
WO2008032222A2 (fr) 2008-03-20
JP2010503658A (ja) 2010-02-04
FR2905600A1 (fr) 2008-03-14
AU2007297181B2 (en) 2013-10-17
AU2007297181A1 (en) 2008-03-20
TW200817030A (en) 2008-04-16
MX2009002725A (es) 2009-03-25
EP2068860A2 (fr) 2009-06-17
FR2943537A1 (fr) 2010-10-01
WO2008032222A3 (fr) 2008-05-02
NZ576150A (en) 2011-11-25
ZA200901452B (en) 2010-04-28
CA2663206A1 (fr) 2008-03-20
FR2943537B1 (fr) 2011-05-13

Similar Documents

Publication Publication Date Title
FR21C1062I1 (fr) Traitement combiné de tumeurs exprimant la cd38
LTC2787345I2 (lt) Fabri ligos gydymo priemonės
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
SMP200900085B (it) 3-imidazolil-indoli per il trattamento di malattieproliferative.
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
BRPI0721213A2 (pt) "regime de dosagem de inibidores da comt"
FR2876047B1 (fr) Traitement de polluants par phytolixiviation
DE602006009764D1 (de) Terphenylderivate zur Alzheimerbehandlung
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
DK1888471T3 (da) Anaerobt rensningsanlæg
ATE496924T1 (de) Prodrugs von 5-amino-3-(3'-deoxy-beta-d- ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion
MA29097B1 (fr) Composes pour le traitement des infections virales par flaviviridae
BRPI0820440A2 (pt) Inibidores aldh-2 no tratamento de desordens psiquiátricas
BRPI0720050A2 (pt) 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
EA200900261A1 (ru) Применение эсцина
FR2897533B1 (fr) Agent oxydant pour le traitement des cheveux
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.
MA28694B1 (fr) Traitement des infections bacteriennes
FR2889518B1 (fr) Systeme pour le traitement des eaux usees domestiques
FR2889976B1 (fr) Appaeil de traitement par voie humide.
DE602008005930D1 (de) 3-(2,2,2-trimethylhydrazinium) propionat-salze zur behandlung des myokardinfarktes
FR2930727B1 (fr) Composition pour le traitement des etats seborrheiques.
AT503071A3 (de) Pflanzenkläranlage

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150529